Dr. Amar Sethi joined VivoSim in November of 2025. He is a physician–scientist and biotechnology executive with 30 years of experience in clinical development, translational medicine, and biomarker innovation. His career is defined by advancing complex therapies through rigorous clinical strategy, science-driven execution, and creation of long-term value for patients and investors. Before joining Vivosim, Dr. Sethi served as Vice President of Clinical Science at Omeros, where he directed protocol design, regulatory engagement, and clinical data strategy across multiple programs in complement-mediated diseases. He also built internal biomarker capabilities to strengthen mechanistic understanding and expand pipeline opportunities. Previously, as President & Chief Medical Officer of Pacific Biomarkers, he guided company strategy, scientific operations, and P&L oversight, driving substantial revenue growth and contributing to the company’s successful acquisition. Earlier roles strengthened his foundation in translational medicine, immunology, clinical assay development, and laboratory operations, providing the scientific and operational depth that underpins his later success in clinical leadership. Dr. Sethi holds an M.D. and Ph.D. and has authored numerous publications and textbook chapters in clinical chemistry and biomarker science.
